Physician

John A Saurino, DO

According to 2025 Medicare claims, John Saurino, DO (NPI: 1245274117) practices ophthalmology in the Tulsa, OK market, with the plurality of this provider's patient population coming from Tulsa, OK. This provider's primary affiliated billing organization is SURGERY WORKS PC (NPI: 1548289721; TIN: 731518671) and primary practice location at 74132-2011.

Saurino's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,508 traditional Medicare patients, billed 29,891 HCPCS/CPT codes, and received $2,288,922 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 1,101 prescription claims across 272 beneficiaries totaling $45,008 in drug costs, led by Lumigan (Bimatoprost). Open Payments data shows 2 records totaling $105. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,218,568 to $2,288,922. In contrast, Part D prescription costs have declined steadily, from $107,955 to $45,008. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.4M$2.9M2015 Medicare payment: $1,218,568 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,381,726 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,378,549 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,572,197 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,702,237 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,825,298 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,877,011 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,551,016 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,233,740 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,288,922 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,66128,891$1,218,568
20161,75533,444$1,381,726
20171,78234,570$1,378,549
20181,77639,658$1,572,197
20191,78536,049$2,702,237
20201,72923,665$2,825,298
20211,58227,864$2,877,011
20221,46825,812$2,551,016
20231,48824,017$2,233,740
20241,50829,891$2,288,922

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$54K$108K2015 Drug cost: $107,955 (USD; Tot_Drug_Cst)2016 Drug cost: $92,090 (USD; Tot_Drug_Cst)2017 Drug cost: $93,643 (USD; Tot_Drug_Cst)2018 Drug cost: $104,203 (USD; Tot_Drug_Cst)2019 Drug cost: $80,166 (USD; Tot_Drug_Cst)2020 Drug cost: $68,631 (USD; Tot_Drug_Cst)2021 Drug cost: $76,296 (USD; Tot_Drug_Cst)2022 Drug cost: $61,499 (USD; Tot_Drug_Cst)2023 Drug cost: $63,831 (USD; Tot_Drug_Cst)2024 Drug cost: $45,008 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152551,163$107,955
20162541,162$92,090
20172711,230$93,643
20182551,244$104,203
2019230898$80,166
2020208784$68,631
2021222927$76,296
2022201917$61,499
2023227927$63,831
20242721,101$45,008

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system731823$78
67028Injection of drug into eye4592,045$76
92012Established patient problem focused exam of visual system6752,012$57
92134Imaging of retina1,4213,179$28
92202Extended exam of the back part of the eye with optic nerve drawing1,3853,069$11

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LumiganBimatoprost301,953$12,182
Prednisolone AcetatePrednisolone Acetate1876,454$8,750
Ketorolac TromethamineKetorolac Tromethamine1415,215$2,929
SimbrinzaBrinzolamide/Brimonidine Tart14514$2,776
Ciprofloxacin HclCiprofloxacin Hcl1874,013$2,241

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$105Iridex Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for John A. Saurino, DO?

Tedicare shows public-source Medicare data for John A. Saurino, DO (NPI 1245274117), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John A. Saurino, DO have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John A. Saurino, DO?

John A. Saurino, DO is linked to SURGERY WORKS PC (billing NPI 1548289721) in the available physician profile data.

Does John A. Saurino, DO have Open Payments data?

John A. Saurino, DO has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.